Israel Englander Palatin Technologies Inc Transaction History

Millennium Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.5 $24,509 - $45,388	-90,777 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.37 - $0.54 $33,587 - $49,019	90,777 New	90,777 $42,000
Q4 2021 Feb 14, 2022	SELL	$0.34 - $0.86 $8,821 - $22,312	-25,945 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$0.44 - $0.63 $10,735 - $15,370	-24,398 Reduced 48.46%	25,945 $11,000
Q2 2021 Aug 16, 2021	BUY	$0.48 - $0.72 $15,018 - $22,528	31,289 Added 164.21%	50,343 $31,000

Q1 2021 May 17, 2021	SELL	$0.68 - $1.25 $3,831 - $7,043	-5,635 Reduced 22.82%	19,054 $13,000
Q4 2020 Feb 16, 2021	BUY	$0.38 - $0.78 $9,381 - $19,257	24,689 New	24,689 $17,000
Q3 2020 Nov 16, 2020	SELL	$0.47 - $0.64 $47,990 - $65,349	-102,108 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.41 - $0.73 $41,864 - $74,538	102,108 New	102,108 $52,000
Q2 2018 Aug 14, 2018	SELL	$0.91 - $1.45 $224,667 - $357,986	-246,887 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$0.84 - $1.18 $21,697 - $30,479	-25,830 Reduced 9.47%	246,887 $269,000
Q4 2017 Feb 14, 2018	BUY	$0.68 - $1.0 $169,059 - $248,617	248,617 Added 1031.61%	272,717 $234,000
Q3 2017 Nov 14, 2017	BUY	$0.39 - $0.66 $9,399 - $15,906	24,100	24,100 $16,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $16.7M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.